Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

iRhythm Holdings Q3 2026 Results: Net Loss of $29.9M, Loss Widens

For the nine months ended September 30, 2026, iRhythm reported revenue of $645.2 million, a 19.9% increase over the prior year, though it incurred a net loss from operations of $51.3 million. Financial results were significantly impacted by $63.7 million in litigation settlements and an acquisition of Vital Connect, Inc. mentioned in forward-looking statements.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue221.6192.9
Gross profit164.5137.1
Profit before tax-29.9-5.2
Net income-29.9-5.2
EPS (diluted, $ a share)$-0.90$-0.16

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+14.9%
Gross margin74.2%
Operating margin-14.7%
Source

10-Q filed with the SEC, NASDAQ: IRTC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

iRhythm Holdings, Inc.: key numbers

Share price
$90.83Close, Nov 16
Market cap
$3.05B
Shares outstanding
33.62MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from iRhythm Holdings, Inc.

All →
6:07 AM ET 8-K
Executive Compensation

iRhythm Holdings Executive Compensation

iRhythm Holdings adopted a new nonqualified Deferred Compensation Plan effective January 1, 2027, for eligible employees and non-employee directors. The plan allows participants, including named executive officers, to defer up to 80% of base salary and 100% of annual bonuses or cash fees into notionally invested accounts. While the plan is unfunded, the company intends to establish a trust to hold assets for these future obligations.

6:07 AM ET 8-K
Stock Buyback

iRhythm Holdings Announces $200M Stock Buyback

iRhythm Holdings' board of directors has authorized a new share repurchase program to buy back up to $200 million of its outstanding common stock. The company plans to fund the repurchases using existing cash and cash equivalents and ongoing cash from operations. The authorization reflects management's confidence in the core business and growth opportunities following the recent acquisition of VitalConnect.

Value
$200M
4:19 PM ET 8-K
Financial Results

iRhythm Holdings Financial Results

iRhythm Holdings reported Q3 2026 revenue of $221.6 million, a 14.9% year-over-year increase driven by strong volume demand for its Zio Monitor. The company also announced the completion of its acquisition of VitalConnect on October 5, 2026, and the closing of a new $300 million revolving credit facility.

Term
Q3 2026

“Our third quarter results reflect the continued strength of our core business. Demand for Zio Monitor remains robust, exceeding our expectations in the quarter, driven by volume growth across care settings and channels. We also continued to take meaningful steps forward with significant margin expansion, and consistent execution against our strategic priorities.”

Quentin Blackford, President and Chief Executive Officer
9:07 AM ET 8-K
M&A Deal

iRhythm Holdings Signs $238M M&A Deal with Vital Connect, Inc.

iRhythm Holdings completed its acquisition of Vital Connect, Inc. for $237.5 million in cash. The deal expands iRhythm's cardiac monitoring portfolio into mobile cardiac telemetry (MCT) and multi-vitals monitoring across ambulatory, inpatient, and hospital-to-home care settings.

Value
$238M
Counterparty
Vital Connect, Inc.
5:01 PM ET 8-K
M&A Deal

iRhythm Holdings M&A Deal with Vital Connect, Inc.

iRhythm Holdings provided a status update on its pending acquisition of Vital Connect, Inc., announcing that the HSR Act antitrust waiting period expired on September 18, 2026. The company now expects the transaction to close in early October 2026, subject to customary closing conditions.

Counterparty
Vital Connect, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.